Haemophilus Influenzae (Hib) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried
Condition:   Haemophilus Influenzae Type b InfectionsInterventions:   Biological: Minhai-HIB;   Biological: Act-HIB®Sponsor:   Beijing Minhai Biotechnology Co., LtdRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2015 Category: Research Source Type: clinical trials

Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine
Conditions:   Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis;   Hepatitis B;   Haemophilus Influenzae Type bInterventions:   Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™);   Biological: DTaP-IPV-Hep B-PRP-T combined vaccine (Hexaxim™)Sponsor:   Sanofi Pasteur, a Sanofi CompanyRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2015 Category: Research Source Type: clinical trials